Related Experiment Video
Updated: Mar 22, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Cardiac dysfunction and prenatal exposure to venlafaxine
Ana R Araújo1, Mónica Marçal2, Madalena Tuna2
1Pediatric Cardiology Department Hospital de Santa Cruz Centro Hospitalar de Lisboa Ocidental Lisboa Portugal.
Maternal venlafaxine use during pregnancy may lead to neonatal transient ventricular dysfunction. This study highlights a potential side effect of this antidepressant in newborns, emphasizing the need for awareness.
Area of Science:
- Neonatal medicine
- Pharmacology
- Cardiology
Background:
- Venlafaxine is a commonly prescribed antidepressant.
- Venlafaxine is associated with withdrawal syndromes.
- Prenatal exposure to venlafaxine is a growing concern.
More Related Videos
Related Concept Videos
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
A study on guinea pigs examined the...
Teratogenicity
Drug Toxicity: Risk factors
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Factors Affecting Drug Response: Overview
Antidepressant Drugs: Overview

